Melanoma is the most serious type of skin cancer. It affects young adults as well as older people. If diagnosed at an early stage, before it has spread, treatment is likely to be curative. The outlook is not so good if it has spread before being treated. See your doctor if you develop an abnormal patch of skin or a change in appearance of a mole.
Understanding the skin
The skin has two layers - the epidermis and the dermis. Beneath the dermis is a layer of fat, and then the deeper structures such as muscles and tendons.
The epidermis has three main types of cell:
- Basal cells. These are the bottom layer of cells in the epidermis.
- Keratinocytes. These cells are in layers above the basal layer. They make a substance called keratin which is a hard wax-like material. Keratinocytes are constantly dividing and a certain number are dying at any given time. The top horny layer of the epidermis is made of dead keratinocytes which contain keratin. The top of the skin is constantly being shed and replaced by new dead cells which contain keratin.
- Melanocytes. These cells are dotted about at the bottom of the epidermis. They make a pigment called melanin when the skin is exposed to sun. Melanin passes to nearby skin cells to protect them from the sun's rays. Melanin causes the skin to tan in fair-skinned people. Dark-skinned people have more active melanocytes.
What are cancer, skin cancer and tumours?
Cancer is a disease of the cells in the body. The body is made up from millions of tiny cells. There are many different types of cell in the body, and there are many different types of cancer which arise from different types of cell. What all types of cancer have in common is that the cancer cells are abnormal and multiply out of control.
Skin cancer is the most common cancer in the UK. Around 100,000 cases are diagnosed each year in the UK. Skin cancers are divided into:
- Melanoma (malignant melanoma). These cancers develop from melanocytes.
- Non-melanoma skin cancers. These are about 20 times more common than melanomas. These are divided into:
- Basal cell carcinoma (BCC) - which develops from basal cells.
- Squamous cell carcinoma (SCC) - which develops from keratinocytes.
- Other - other types of skin cancer, which are rare.
A malignant tumour is a lump or growth of tissue made up from cancer cells which continue to multiply. Malignant tumours invade into nearby tissues and organs, which can cause damage.
Malignant tumours may also spread to other parts of the body. This happens if some cells break off from the first (primary) tumour and are carried in the bloodstream or lymph channels to other parts of the body. These small groups of cells may then multiply to form secondary tumours (metastases) in one or more parts of the body. These secondary tumours may then grow, invade and damage nearby tissues, and spread again.
The rest of this leaflet is just about melanoma. See separate leaflet called Skin Cancer - Non-melanoma for further detail on non-melanoma skin cancer.
How common is melanoma?
Melanoma is the least common form of skin cancer, but it is the most serious. It is the one most likely to spread to other parts of the body. There are about 9,000 new cases of melanoma each year in the UK. The number of cases has about doubled over a period of 20 years or so. Melanoma is the second most common cancer in people aged 15-34.
What causes melanoma?
A cancerous tumour starts from one abnormal cell. The exact reason why a cell becomes cancerous is unclear. It is thought that something damages or alters certain genes in the cell. This makes the cell abnormal and multiply out of control. (See separate leaflet called Cancer - What Causes Cancer for more details.)
Sun or sunbed damage to skin
The main risk factor which damages skin and can lead to a melanoma is damage from the sun. It is the ultraviolet (UV) radiation in the sunshine and in sunbeds which does the damage. About 6 in 10 cases of melanoma are thought to be caused by UV damage. UV light damages the DNA (genetic material) in your skin cells which can then lead to skin cancers developing.
People most at risk to UV skin damage are people with fair skin - in particular, those with skin which always burns and never tans, red or blond hair, green or blue eyes. Melanoma is uncommon in dark-skinned people, as they have more protective melatonin in their skin.
Children's skin is most vulnerable to damage. Sun exposure in childhood is the most damaging. People who had a lot of freckling in childhood, or had frequent or severe sunburn in childhood, are most at risk of developing melanoma as adults. (The damage to the skin can occur many years before a cancer actually develops.)
Melanoma is most common in fair-skinned people who live in hot countries nearer to the equator. Australia and Israel have the highest rates. The rate in the USA is quite high, but decreases the further north you go in the country.
Other risk factors
Other factors which increase the risk of developing melanoma include the following:
- A family history. If a close blood relative develops melanoma then your risk is approximately doubled. This increased risk may be due to a shared family lifestyle of frequent sun exposure and/or having fair skin. It may also be due to inherited faulty genes. Around one in ten people with melanoma will have a relative who has also had a melanoma. Further research aims to clarify the role of these and other genes which may be involved. Gene testing for melanoma is not yet possible. As a rule, if you have a family history of melanoma you should take extra care to protect your skin from sun damage. Also, check your skin regularly for early signs of melanoma (see below).
- Having many moles. These are the small brown marks which occur on almost everybody. They are caused by a collection of melanocytes in the skin surface. If you have many (especially 100 or more) you have an increased risk that one will develop into a melanoma.
- Atypical (non-typical) moles. People with moles which are bigger than usual, with an irregular shape or colour (called atypical), have an increased risk. These moles (sometimes called dysplastic naevi) rarely change into melanoma, but it's important to keep an eye on them. If you have a strong family history of melanoma (father, mother, brother or sister with a melanoma), and you have an atypical mole, you have a high risk of developing melanoma. Make sure you check your skin regularly.
- Using sunbeds or similar tanning machines which emit UV light. Damage caused by sunbeds seems to be worse in people with red hair and freckles and also in young people under the age of 20 years.
- Having a weakened immune system (for example, due to HIV infection, or if you are taking immunosuppressive drugs, perhaps after an organ transplant) then you have an increased chance of getting a melanoma.
What are the symptoms of melanoma?
See DermNet NZ for pictures of different melanomas: http://dermnetnz.org/lesions/melanoma.html
A typical melanoma starts as a small dark patch on the skin. It can develop from a normal part of skin, or from an existing mole. A melanoma is often different to a mole in one or more of the following ways (summed up as ABCDE) - that is:
- A symmetry - the shape of a melanoma is often uneven and asymmetrical, unlike a mole which is usually round and even.
- B order - the border or edges of a melanoma are often ragged, notched or blurred. A mole has a smooth well-defined edge.
- C olour - the colour (pigmentation) of a melanoma is often not uniform. So there may be 2-3 shades of brown or black. A mole usually has one uniform colour.
- D iameter - the size of a melanoma is usually larger than 6 mm and it continues to grow. However, they can sometimes be smaller than this.
- E volving - any change in size, shape, colour, elevation or any new symptom such as bleeding, itching or crusting may be due to a melanoma.
However, some melanomas are not dark, and some melanomas are not typical in how they look. As a melanoma grows in the skin, it may itch, bleed, crust or ulcerate.
The take home message is: see a doctor if you develop a lump or patch on the skin, which you are unsure about, or if a mole changes in its shape, border, colour or size.
A melanoma can develop on any area of skin. The most common place for a melanoma to develop in a woman is on the legs; whereas for men it is on the chest or back. Rarely, a melanoma can develop in the iris or back of the eye. (Unlike non-melanoma skin cancers, melanomas can develop on areas of skin not often exposed to the sun. These areas may have had short spells of sun damage such as during a holiday.)
If some cells break off and spread (metastasise) to other parts of the body, various other symptoms can develop. A common early symptom of spread is for the nearby lymph glands (nodes) to swell.
How is a melanoma diagnosed?
If a melanoma is suspected then your doctor is likely to advise an excisional biopsy. This is where the entire abnormal area of skin is removed by a minor operation. (Local anaesthetic is injected into the skin to make this painless.) This tissue is looked at under the microscope. This is to:
- Confirm the diagnosis - abnormal melanoma cells can be seen.
- To assess the melanoma's thickness (how deep it has spread into the skin.) The thickness of the melanoma helps to guide treatment and the need for further assessment.
Initial treatment and assessment of melanoma
The excisional biopsy may be curative
When doing an excisional biopsy (described above) the doctor will remove a margin of normal skin around the melanoma. When the biopsy is looked at under the microscope, if the doctor is sure that all the melanoma cells have been removed, and the melanoma cells are confined to the top layer of skin, then no further treatment may be needed. Otherwise, a second operation called a wide local excision is usually advised.
Wide local excision may be needed
This aims to remove an area of normal skin around where the melanoma had been (before it was removed with excisional biopsy). This aims to make sure that any cells which may have grown in the local area of skin have been removed. The amount of normal looking skin removed varies - depending on the thickness of the melanoma (how deep it has spread into the skin) as reported from the biopsy. It may be 1-2 cm around where the melanoma had been. This operation may be done under local or general anaesthetic. In some cases a skin graft may be needed to cover the wound.
Staging of melanoma
The aim of staging is to find out how much a cancer has grown and spread. Finding out the stage of the cancer helps doctors to advise on the best treatment options. It also gives a reasonable indication of outlook (prognosis). (See separate leaflet called Staging and Grading Cancer for further details).
Most cases of melanoma are diagnosed at stage one when there is a very good chance that treatment will cure the condition. Other stages (2-4) are diagnosed if the tumour has spread. The stage diagnosed depends on how much and how far the the original tumour has spread to other parts of the body.
How is melanoma assessed and staged?
If the initial biopsy and the tissue taken from the wide local excision show that the melanoma is just in the top layer of skin and is less than 0.76 mm thick, then no further tests are usually needed. It is highly unlikely that it will have spread. This is an early stage 1 melanoma.
A doctor will examine you to see if you have any swollen lymph nodes (glands) near to the melanoma. If you have, then the melanoma may have spread to these local lymph nodes.
It is possible that there may be some early spread without causing symptoms if the melanoma is thicker than 0.76 mm on the initial biopsy. In particular, there may be spread of some cells to the nearest lymph node without it yet causing it to swell. Therefore, a test called sentinel node biopsy, and sometimes other tests, may be advised.
Sentinel node biopsy. This is a relatively new test which may be considered. In this test, a small sample of the nearest lymph node is taken as an additional procedure when the melanoma is being removed. However, sentinel node biopsy is not used routinely, and is usually performed only as part of a research study. This means that it is not an essential part of treatment.
Other tests. Tests which may be advised depend on: whether you have symptoms; whether the lymph nodes are found to be involved; the thickness of the primary melanoma (the thicker the primary tumour, the greater the chance of spread). The tests aim to detect if the cancer has spread to other parts of the body. For example, you may be advised to have X-rays, blood tests, scans, etc.
What is the treatment for melanoma?
The treatment depends on the stage. Generally, if the melanoma is thin then a small operation to cut out the tumour (the biopsy or wide local excision described above) is usually all the treatment that is needed. This is likely to clear all the cancer cells. Following the treatment you will usually be seen at regular intervals.
If the melanoma is deeper then you may need a larger operation which may include removing the local lymph nodes. You may also be given additional treatment, depending on where the cancer has spread to and what symptoms you have. This may include:
- Chemotherapy. This is a treatment which uses anti-cancer medicines to kill cancer cells or to stop cancer cells from multiplying.
- Radiotherapy. This treatment uses high-energy beams of radiation which are focused on cancerous tissue. This kills cancer cells, or stops the cells from multiplying.
- Immunotherapy. This aims to boost the immune system to help to fight cancer.
What is the outlook (prognosis)?
The prognosis for people with malignant melanomas has been improving over a period of 25 years and people with melanomas now have amongst the best outlook for any cancer. Around three quarters of people who have a melanoma removed will have no further problems.
The outlook depends on the stage. Most cases of stage 1 melanoma are cured with a minor surgical operation to remove the tumour (described above). For people with deeper melanomas then there is still a chance of cure. People with advanced melanoma that has spread to other parts of the body are not likely to be cured, but treatment can often slow down the progression of the cancer.
The treatment of cancer is a developing area of medicine. New treatments continue to be developed and the information on outlook above is very general. The specialist who knows your case can give more accurate information about your particular outlook, and how well your type and stage of cancer is likely to respond to treatment.
Can melanoma be prevented?
Most skin cancers (non-melanoma and melanoma skin cancers) are caused by excessive exposure to the sun. We should all limit our sun exposure in the summer months (or all year when in hot countries nearer the equator) by:
- Staying indoors or in the shade as much as possible between 11 am and 3 pm.
- Covering up with clothes and a wide-brimmed hat when out in the sunshine.
- Applying sunscreen with a sun protection factor (SPF) of 15 (SPF 30 for children or people with pale skin) which also has high ultraviolet A (UVA) protection.
In particular, children should be protected from the sun. Sunburn or excessive exposure to the sun in childhood is thought to be the biggest risk factor to the developing of skin cancer as an adult. Also, people with a family history of melanoma should take extra care to protect their skin from the sun.
See separate leaflet called Preventing Skin Cancer for details.
Further help and information
Macmillan Cancer Support
Tel (Helpline): 0808 808 00 00 Web: www.macmillan.org.uk
Provide information and support to anyone affected by cancer.
Web: http://cancerhelp.cancerresearchuk.org/ provides facts about cancer, including treatment choices.
Other support groups
See www.patient.co.uk/selfhelp.asp for a list of support groups for cancer patients.
Further reading & references
- Improving Outcomes for People with Skin Tumours including Melanoma, NICE (Update May 2010)
- Guidelines for the management of cutaneous melanoma, British Association of Dermatologists (2010)
- Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up; European Society for Medical Oncology (2010)
- Bataille V, de Vries E; Melanoma--Part 1: epidemiology, risk factors, and prevention. BMJ. 2008 Nov 20;337:a2249. doi: 10.1136/bmj.a2249.
- Thirlwell C, Nathan P; Melanoma--part 2: management. BMJ. 2008 Dec 1;337:a2488. doi: 10.1136/bmj.a2488.
|Original Author: Dr Tim Kenny||Current Version: Dr Colin Tidy||Peer Reviewer: Dr John Cox|
|Last Checked: 16/05/2012||Document ID: 4849 Version: 40||© EMIS|
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.